The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.
Search Terms:
Investigator: Marta Stojanovic
Project Title: Associations between resting state functional connectivity and depression in Alzheimer disease
Date: March 19, 2024 at 4:25 pm
Request ID: D2411
Aim 1: Examine whether resting state functional connectivity networks are associated with depression, as indicated by depressive symptoms and depression diagnosis.
Aim 2: Examine whether AD pathology moderates the association between resting state functional connectivity networks and depression.
Aim 3: Investigate whether use of antidepressants (e.g., SSRIs) moderates the relationship between resting state functional connectivity and depression.
Aim 4:
Investigator: Tammie L. S. Benzinger
Project Title: Identifying the Social Determinants of Individuals Undergoing Amyloid PET without a Structural MRI
Date: March 14, 2024 at 8:45 am
Request ID: D2410
Aim 1: We aim to validate a MR-free PET quantification pipeline against an established MR-dependent PET quantification method (i.e., FreeSurfer-based PUP) on a pooled cohort from SEABIRD, the Knight ADRC, and the SORTOUT-AB studies.
Aim 2: We aim to identify the common demographic and socioeconomic characteristics of those with missing or unusable MR scans in the above-mentioned cohort.
Aim 3: We aim to ascertain the percentage of previously unusable data points recovered by using the MR-free PET pipeline, as well as the estimated cost-savings on data collection.
Aim 4:
Investigator: Arash Nazeri
Project Title: Understanding the Links between CSF Circulation and Alzheimer’s Disease Biomarkers
Date: March 7, 2024 at 10:59 pm
Request ID: D2409
Aim 1: To determine the correlation between CSF flow patterns and the CSF and PET biomarkers of Alzheimer’s disease.
Aim 2: To investigate the relationship between CSF flow patterns and CSF biomarker kinetics using SILK.
Aim 3: To examine how CSF flow patterns modulate the interrelationship between plasma and CSF proteome.
Aim 4:
Investigator: Armentrout
Project Title: Evaluation of the CTX Mobile Cognitive Health Application
Date: March 7, 2024 at 3:04 pm
Request ID: D2408
Aim 1: Develop new and engaging cognitive tests and pipelines for assessing visual search and targeting, expressive and receptive language, motor movement and episodic memory
Aim 2: Validate measures in cognitively normal and impaired cohorts; and (3) Analyze and prepare data for publication and premarket submissions to the FDA.
Aim 3:
Aim 4:
Investigator: Esther Lu & Qing Wang
Project Title: Change-point analysis of Alzheimer disease
Date: March 6, 2024 at 7:48 pm
Request ID: D2407
Aim 1: to identify change-points of DBSI using a new algorithm of pruned exact linear time with a cost based on the empirical distribution (ED-PELT).
Aim 2: to examine the trends in the DBSI and other biomarkers on the AD diagnosis using a generalized linear change-point model (GLCPM).
Aim 3:
Aim 4:
Investigator: Chia-Ling Phuah
Project Title: Genetic risk Of Alzheimer’s disease on Traumatic Brain Injury
Date: February 29, 2024 at 1:33 pm
Request ID: D2406
Aim 1: Determine if genetic risk for AD influences cognitive impairment after TBI
Aim 2: Assess if AD genetic risks modulate the relationship between TBI and imaging markers of neurodegeneration
Aim 3:
Aim 4:
Investigator: Zhibo Wang
Project Title: Exploring Biomarkers Related to Alzheimer’s Disease: A Pathway to Diagnosis, Staging, and Therapeutic Targets
Date: February 23, 2024 at 11:24 am
Request ID: D2405
Aim 1: To identify biomarkers that provide a basis for the pathological diagnosis of Alzheimer’s Disease, enhancing early detection and accurate diagnosis.
Aim 2: To characterize the pathophysiological features of Alzheimer’s Disease at various stages, aiding in the understanding of its progression and impact.
Aim 3: To discover potential therapeutic targets among the identified biomarkers, opening avenues for the development of targeted treatments for AD.
Aim 4: To investigate biomarkers associated with the progression of Alzheimer’s Disease, contributing to the prediction and monitoring of disease advancement.
Investigator: Oskar Hansson
Project Title: Improved precision of Alzheimer’s disease fluid biomarkers when using Amyloid-β40 or non-phosphorylated tau as a reference
Date: February 15, 2024 at 6:30 am
Request ID: D2404
Aim 1: Investigate if several already high performing CSF and plasma AD biomarkers can be improved by normalizing their concentrations to a reference protein (e.g., Aβ40 and non-phosphorylated mid-region tau [nP-tau]). For further details, see the file which was emailed to Marissa Streitz.
Aim 2:
Aim 3:
Aim 4:
Investigator: Iman Beheshti
Project Title: Association between inflammatory factors and accelerated brain aging in Alzheimer’s disease.
Date: February 5, 2024 at 2:01 pm
Request ID: D2403
Aim 1: To compute brain age estimation (as a new metric reflecting brain health) using advanced ML models and structural MRI data in the field of AD.
Aim 2: To uncover the impact of inflammatory factors on the increased development of AD and the rate of AD progression.
Aim 3: To understand the association between tau features on brain age estimation in diverse form of AD
Aim 4: To find the association between medications taken by patients with the risk of developing AD and AD progression using the brain age estimation model.
Investigator: Iman Beheshti
Project Title: Association between inflammatory factors and accelerated brain aging in Alzheimer’s disease using OASIS3 data.
Date: February 5, 2024 at 12:41 pm
Request ID:
Aim 1: To compute brain age estimation (as a new metric reflecting brain health) using advanced ML models and structural MRI data in the field of AD.
Aim 2: To uncover the impact of inflammatory factors on the increased development of AD and the rate of AD progression.
Aim 3: To understand the association between tau features on brain age estimation in diverse form of AD
Aim 4: